BIOSPECIMEN PROCESSING CENTER (BPC) - EARLY ONSET MALIGNANCIES INITIATIVE

本任务令为早发性恶性肿瘤倡议（EOMI）提供支持。EOMI是CCG和癌症预防部门NCI社区肿瘤研究计划（NCORP）之间的一项合作倡议，旨在调查为什么某些种族和民族人群在早期患癌症的风险增加。EOMI将重点关注六种癌症类型，这些癌症在某些少数民族人群中发展较早，发生率较高，通常更具侵袭性。癌症基因组学中心（CCG）生物标本处理中心（BPC）通过提供以下服务支持EOMI基因组学项目：生物标本和相关数据采购，生物标本管理和生物库操作，生物标本组织学审查，生物标本加工成分子分析物，以及生物标本和分析物分布。

This Task Order provides support to the Early Onset Malignancies Initiative (EOMI). The EOMI is a collaborative initiative between CCG and the Division of Cancer Prevention’s NCI Community Oncology Research Program (NCORP) investigating why certain racial and ethnic populations are at increased risk of developing cancer at an early age, The EOMI will focus on six cancer types that in certain minority populations develop at an earlier age, occur in higher rates, and are typically more aggressive. The Center for Cancer Genomics (CCG) Biospecimen Processing Center (BPC) supports the EOMI genomics projects by providing the following services: Biospecimen and associated Data Procurement, Biospecimen Management and Biorepository Operations, Biospecimen Histological Review, Biospecimen Processing into Molecular Analytes, and Biospecimen and Analyte Distribution.